PRKCE and ovarian cancer: Moreover, KLF9 expression was considerably lower (0.61 ± 1.6) in ovarian cancer patients than in healthy controls, but the miR-223 expression was up-regulated (2.9 ± 4.0), and PKCε expression was reduced in ovarian cancer patients.